IN RE: GREGORY A. BRANDT, JOHN B. LETTS, FIRESTONE BUILDING PRODUCTS COMPANY, LLC
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Lourie, Reyna, and Taranto. Appeal from the Patent Trial and Appeal Board.
Summary: A prima facie case of obviousness is established where the claimed range abuts a range disclosed in the prior art and there is no evidence of a meaningful distinction between the two ranges.
The claims at issue were directed to a roof that included a coverboard with a density greater than 2.5 lbs/ft3 and less than 6 lbs/ft3. The prior art taught a coverboard with a core layer having a density between 6 lbs/ft3and 25 lbs/ft3. Applicant argued the Examiner did not establish a prima facie case of obviousness because the ranges abutted each other, but did not overlap. The Board affirmed the rejection because “a prima facie rejection is properly established when the difference in the range or value is minor.” Applicant appealed to the Federal Circuit.
The Federal Circuit noted Applicant presented no rebuttal evidence of unexpected results or criticality. Thus, the Federal Circuit considered only whether substantial evidence supported the prima facie obviousness case. The Federal Circuit affirmed, holding that “because the claimed range and the prior art range abut one another, and Appellants conceded as fact that there is no meaningful distinction between the two ranges, substantial evidence supports the Board’s finding that the difference in coverboard density ranges ‘could not be smaller.’”
This case is: IN RE: GREGORY A. BRANDT, JOHN B. LETTS, FIRESTONE BUILDING PRODUCTS COMPANY, LLC
Written by: Adam Powell and Peter A. Hecker, Ph.D.
Edited by: Paul Stewart
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…